期刊
BRAIN
卷 138, 期 -, 页码 3581-3597出版社
OXFORD UNIV PRESS
DOI: 10.1093/brain/awv289
关键词
remyelination; ageing; retinoid X receptor; myelin debris; monocyte-derived macrophages
资金
- UK Multiple Sclerosis Society
- Wellcome-Trust
- NINDS/NIH Intramural Research Program
- Health Research Board Scholars Program
- Gates-Cambridge Scholarship
- Spanish Ministry of Economy and Competitiveness [SAF2012-31483]
- BBSRC [BB/J01026X/1] Funding Source: UKRI
- MRC [MC_PC_12012] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/J01026X/1] Funding Source: researchfish
- Medical Research Council [MC_PC_12012] Funding Source: researchfish
- Rosetrees Trust [M144] Funding Source: researchfish
The efficiency of central nervous system remyelination declines with age. This is in part due to an age-associated decline in the phagocytic removal of myelin debris, which contains inhibitors of oligodendrocyte progenitor cell differentiation. In this study, we show that expression of genes involved in the retinoid X receptor pathway are decreased with ageing in both myelin-phagocytosing human monocytes and mouse macrophages using a combination of in vivo and in vitro approaches. Disruption of retinoid X receptor function in young macrophages, using the antagonist HX531, mimics ageing by reducing myelin debris uptake. Macrophage-specific RXR alpha (Rxra) knockout mice revealed that loss of function in young mice caused delayed myelin debris uptake and slowed remyelination after experimentally-induced demyelination. Alternatively, retinoid X receptor agonists partially restored myelin debris phagocytosis in aged macrophages. The agonist bexarotene, when used in concentrations achievable in human subjects, caused a reversion of the gene expression profile in multiple sclerosis patient monocytes to a more youthful profile and enhanced myelin debris phagocytosis by patient cells. These results reveal the retinoid X receptor pathway as a positive regulator of myelin debris clearance and a key player in the age-related decline in remyelination that may be targeted by available or newly-developed therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据